Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected Patients

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 3

Conditions: Varicella

Treatments: Procedure: Collection of clinical samples

Study type: Interventional

Funder types: Industry

Identifiers

NCT00127608

103815

Details and patient eligibility

About

This study is conducted in order to collect clinical samples from patients who are diagnosed of having chickenpox infection. The results of this study will provide basic scientific information about chickenpox disease.

Full description

The study involves NO therapeutic or prophylactic treatment nor further observation of the patients. There is no product to be tested in this study.

Enrollment: 36 patients

Sex: All

Ages: 1 day to 16 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Pediatric patients who are diagnosed of having varicella and are presenting varicella dermal lesions.

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

36 participants in 1 patient group

Varicella Group

Experimental group

Description:

Subjects aged between 0 and 16 years of age, with clinically-diagnosed primary varicella disease.

Treatment:

Procedure: Collection of clinical samples